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Microsomal cytochrome b 5 is a ubiquitous, 15.2 kDa hemoprotein associated primarily with the endoplasmic reticulum of eukaryotic cells. In conjunction with its primary electron donor cytochrome b 5 reductase, this protein has been associated with many important cellular processes. Probably the most characterized is in the cytochrome P450 (P450) -mediated metabolism of xenobiotics and drugs (Porter, 2002; Schenkman and Jansson, 2003; Yamaori et al., 2003; Yamazaki et al., 2002; Zhang et al., 2005) ; and in cholesterol and steroid hormone homeostasis (Akhtar et al., 2005; Lamb et al., 2001) . These effects on cytochrome P450 activity are very much substrate-and P450-specific, with evidence of both stimulation and inhibition of P450 turnover (Porter, 2002; Schenkman and Jansson, 2003; Waskell et al., 1986; Zhang et al., 2008; Zhang et al., 2007) . After almost 40 years of research however, the mechanism of this interaction is still being described as "enigmatic" (Schenkman and Jansson, 2003) and "controversial" (Hildebrandt and Estabrook, 1971; Porter, 2002) ; and has been the focus of many, often contradictory, literature reports (Guryev et al., 2001; Yamazaki et al., 2002) .
The other (non-P450 related) functions of cytochrome b 5 include the reduction of heavy metals, carcinogenic arylhydroxylamines (Borthiry et al., 2007; Kurian et al., 2007) , fatty acid desaturation and methemoglobin /haemoglobin cycling (Jeffcoat et al., 1977; Umbreit, 2007) . Furthermore, cytochrome b 5 is also thought to play a role in the biosynthesis of plasmalogens which are glycerol-based phospholipids, found in heart and neuronal tissues (Lee et al., 1991; Paltuaf et al., 1974; Woelk and Jahrreiss, 1978) .
In order to establish the in vivo functions of this protein, we have recently generated a mouse where microsomal cytochrome b 5 was conditionally deleted in the liver (HBN mice) (Finn et al., 2008) . HBN mice had significantly reduced in vitro rates of hepatic NADPHand NADH-dependent metabolism of a range of model P450 substrates and probe drugs; We have now generated a mouse model where the cytochrome b 5, has been deleted in all mouse tissues (b 5 complete null (BCN)). BCN mice were viable and fertile and in this report we describe the effects of cytochrome b 5 deletion on the expression of drug metabolising enzymes and on hepatic and extra-hepatic foreign compound metabolism.
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Materials and Methods
Chemicals -All reagents unless stated were purchased from Sigma-Aldrich (Poole, UK).
NADPH was obtained from Melford Laboratories (Ipswich, UK).
7-Benzyloxy-4-trifluoromethylcoumarin (BFC), 7-methoxy-4-trifluoromethylcoumarin (MFC) and 7-hydroxy-4-trifluoromethylcoumarin (HFC) and hydroxy-tolbutamide, were purchased from BD Gentest, Cowley, UK. Midazolam, 1-hydroxy midazolam and 4-hydroxy midazolam were kind gifts from Roche (UK) and 1-hydroxy metoprolol and O-desmethyl metoprolol were generous gifts from Astra Häsle (Mölndal, Sweden). PCR primers were obtained from
Eurofins MWG Operon (Ebersberg, Germany)
Generation of Cytochrome b 5 Complete Null (BCN) Mice -Cytb 5
lox/lox mice were generated as previously described (Finn et al., 2008) and maintained by random breeding on a 129P2 X C57BL/6 genetic background. Preparation of microsomes -Microsomes were prepared from wild-type and BCN mouse tissues, using 0.3 -0.5g of tissue, by the method of Meehan et. al. (Meehan et al., 1988) for the small intestine and by a modified method of this method for all other tissues, using sonication instead of mechanical homogenisation (Pritchard et al., 1998) . Microsomal protein concentrations were determined using the Biorad Protein Assay Reagent (Bio-Rad Labs Ltd, Herts UK). P450 oxidoreductase (POR) activity was estimated by NADPH-dependent cytochrome c reduction (Strobel and Dignam, 1978) . Microsomes were stored at -70˚C until required.
Quantitiation of microsomal cytochrome b 5 -The specific amount (pmol cytochrome b 5 /mg of microsomal protein) of cytochrome b 5 expressed in various tissues was determined by NADH-reduced spectrophotometry as follows: a know volume of microsomes were resuspended in 2ml of 100 mM potassium phosphate buffer pH 7.4 and the suspension split between two matched quartz cuvettes. An absorbance baseline was plotted between 400 -500 nm, following which NADH was added to the sample cuvette to a concentration of 200 μM and a reduced spectrum determined. The amount of cytochrome b 5 in the sample was calculated by determining the absorbance difference between 426 nm and 409 nm using an extinction coefficient of 185,000 L/mol. Data is the mean of three animals (per tissue) ± s.d.
Immunoblotting -Immunoblot analysis was carried as previously described (Finn et al., 2008 Reactions were carried out in triplicate and monitored by measuring fluorescence at 518 nm with excitation at 494 nm. mRNA levels were quantified using the Prism 7700 associated software and normalised to the levels 18s mRNA (Applied Biosystems, Warrington, UK).
P450 spectral analysis -P450 content of mouse liver microsomes was determined by reduced CO difference spectroscopy for three samples of each genotype, using the method described by Omura and Sato (Omura and Sato, 1964) . 
Generic P450 microsomal incubations -
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Fluorogenic assay incubations -Assays were performed essentially as previously described (Finn et al., 2008) Metoprolol -800 µM substrate, 30 µg microsomes in a final volume of 100µl for 60 min;
Phenacetin -50 µM substrate, 20 µg microsomes in a final volume of 100µl for 9 min;
Tolbutamide -800 µM substrate, 30 µg microsomes in a final volume of 10µl for 60 min.
Assays were stopped by the addition of either 0.5 volumes (chlorzoxazone) or 1 volume (tolbutamide, midazolam and phenacetin) of ice cold methanol and incubated on ice for 10 min. Samples were centrifuged for 8 min at 16000 x g to remove particulate material before HPLC (chlorzoxazone) or LC MS-MS (tolbutamide, midazolam and phenacetin) analysis was carried out as previously described (Finn et al., 2008) .
Testicular testosterone content -Testosterone was extracted from the testes of 10 week old mice using the method of Zhang et al (Zhang et al., 2003) and analyzed by reversed phase HPLC (Paine et al., 2003) .
Progesterone and 17α hydroxy-progesterone incubations -Incubations were performed in triplicate in a final volume of 150 μl of 50 mM potassium phosphate buffer; pH 7.4 containing 25 μg of testicular microsomes and either 8 μM progesterone or 15 μM 17α hydroxy-progesterone. Reactions were incubated at 37ºC and were initiated by the addition of NADPH. After 20 min, incubations were stopped by the addition of 75 μl of ice-cold methanol. Samples were incubated on ice for 10, before being centrifuged for 8 min at 16000
x g to remove particulate material before HPLC analysis.
Progesterone and 17α hydroxy progesterone assay HPLC conditions -Substrates and metabolites (progesterone, 17α hydroxy-progesterone, androstenedione and testosterone)
were separated by reversed phase HPLC using a Hypersil ODS column (5 μm; 4 x 250mm (Agilent, Stockport, UK)) maintained at 35 ºC with the following mobile phase conditions: 1-This article has not been copyedited and formatted. The final version may differ from this version. 
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3 min: 2.5% acetonitrile/41%water/56.5% methanol; 3-9 min a linear gradient was applied to reach 5% acetonitrile/25% water/72.5% methanol. This was maintained for a further 2 min before applying a linear gradient for 50 sec to reach the original solvent concentrations, which were maintained for a further 3 min. Metabolites were detected at 240 nm and quantified using authentic standards.
Statistical methods -Average rates of metabolism were calculated for each triplicate incubation of mouse liver microsomes from each genotype (n = 3) and these data were then used to calculate p values using an Unpaired t-test.
In vitro pharmacokinetics of metoprolol -Five, ten week old male mice of each genotype were orally gavaged with metoprolol (2mg/kg). Blood samples were taken and the samples analyzed by LC-MS/MS as previously described (Finn et al., 2008) . Pharmacokinetic parameters were calculated using a non-compartmental model (WinNonLin v4.1 (Pharsight,
Munich, Germany)).
This article has not been copyedited and formatted. The final version may differ from this version. was not necessary for sexual maturation. The BCN mice however did display dry skin and an interesting fur condition where pups and young adult mice had a characteristically dull, sparse coat, with marked pilo-erection, along with a degenerative nurturing phenotype probably related to changes in milk composition. This phenotype was reflected in low neonatal body weights, which improved when the pups were weaned and became normal when the animals reached 6-8 weeks of age. A manuscript documenting these characteristics in detail is currently in preparation. In extra-hepatic tissues, some changes in the levels of cytochrome P450 expression were observed; namely an 80% decrease in the expression of Cyp2e1 was observed in the kidney (p= 0.035), a 35% increase in the expression of Cyp2b (p= 0.004) in the lung, and in the small intestine a 70 % decrease (p= 0.003) in Cyp2d and 40% decrease in Cyp2e (p= 0.03) ( Figure 2B ). No changes in testicular P450 levels were observed (data not shown). The increases in hepatic cytochrome P450 expression were reflected in the mRNA levels for Cyp2a4, Cyp2b10, Cyp3a11 and Cyp4a10 ( Figure 2D ), indicating that the observed increases in protein expression were due to increases in gene transcription, or mRNA stabilization. In order to determine if the changes in P450 expression observed in BCN liver were present from birth hepatic P450 levels were measured in one day old pups (two from each genotype).
Analysis of cytochrome P450-dependent monooxygenase components -
As in the adult mice, Cyp2a, Cyp2b, Cyp3a levels were increased in neonatal BCN liver at this early time-point, while Cyp2c and Cyp2d protein was marginally repressed ( Figure 2E ).
In vitro cytochrome P450 activities -In vitro cytochrome P450 activities in microsomes from
kidney, liver, lung and small intestine of wild-type and BCN mice were determined using a panel of probe substrates comprising alkoxy-resorufin and alkoxy-4-trifluoromethylcoumarin derivatives (Table 1 ). In the case of the alkoxy-resorufins, no differences in the hepatic metabolism of ER or MR between BCN and wild-type mice were observed, whereas the BCN samples exhibited a significantly higher rate of metabolism of BR (4.1-fold) and PR (2.4-This article has not been copyedited and formatted. The final version may differ from this version. than BCN microsomes alone and a 2.3 fold increase above wild-type levels ( Figure 3A) .
Addition of the highest concentration of cytochrome b 5 to wild-type microsomes caused a comparatively small (19%) increase in activity. When this experiment was carried out using BR as a substrate ( Figure 3B ), no increase in wild-type activity was observed; however the activity in BCN microsomes (which was already approximately 2-fold more active towards BR than wild-type) was increased by 4.5-fold by cytochrome b 5 addition, achieving a 7.8-fold increase over the control levels. When cytochrome b 5 was added to wild-type lung microsomal incubations, activities were increased 1.5-and 7-fold for BFC and BR respectively ( Figure 3C and 3D). Addition of the same amount of cytochrome b 5 back to BCN lung microsomes resulted in a 7.4-fold increase in BFC turnover ( Figure 3C ) and the appearance of BR activity ( Figure 3D ). For both substrates these activities were equal to Metabolism of probe drugs -In addition to the use of model substrates, in vitro assays were also performed with probe drug substrates (Figure 4 ). Chlorzoxazone 6-hydroxylation was significantly reduced in liver, lung and kidney by 4-, 2-and 5.5-fold respectively ( Figure 4A ).
In the case of midazolam, the rate of production of the 1′-and 4-hydroxy-midazolam metabolites was also much lower in the BCN samples, reaching statistical significance in the liver and kidney for 1′-hydroxy-midazolam production, and in the liver for midazolam 4-hydroxylation ( Figure 4B ). Metoprolol O-demethylation was significantly reduced in This article has not been copyedited and formatted. The final version may differ from this version. cytochrome b 5 null liver and kidney samples, while no effect was observed in the lung or small intestine samples. 1′-Hydroxy-metoprolol was detected in liver, kidney and small intestine incubations but not in the lung samples. Similarly to O-desmethyl metoprolol production, formation of this metabolite was significantly decreased in the liver and kidney samples of BCN mice ( Figure 4C ). In contrast to the above substrates, metabolism of phenacetin to acetaminophen was significantly increased in the livers of BCN mice (p<0.05) while in the kidney and lung, ablation of cytochrome b 5 had no effect on activity ( Figure 4D ).
In the case of tolbutamide hydroxylation, activity was only detected in liver and kidney microsomes; however, in both cases BCN samples showed lower activity compared to controls. The reduction being significant in the kidney ( Figure 4E ).
In vivo Metoprolol pharmacokinetics -In order to determine if the observed decreases in in
vitro cytochrome P450 metabolism were reflected in vivo, the pharmacokinetics of orally administered metoprolol were determined in wild-type and BCN mice. The elimination profiles of metoprolol disappearance were significantly different between wild-type and BCN mice ( Figure 5 ). The AUC and terminal half-life of metoprolol were significantly increased (3.5-and 2.4-fold respectively) and clearance decreased (3.5-fold) in the BCN animals compared to wild-type. Furthermore, although not statistically significant, the metoprolol C max values were also increased in the BCN (4-fold). Further studies have been carried out which show a clear effect of cytochrome b 5 deletion on the pharmacokinetics of a range of drugs. These data will form the basis of a further manuscript.
Steroid hormone metabolism and testosterone levels -Cytochrome b 5 has been reported to be essential for the conversion of 17α hydroxy-progesterone to androstenedione (Akhtar et al., 2005) . In order to study the pathway of testosterone biosynthesis, we measured progesterone metabolism using testicular microsomes from wild-type and BCN mice. A significant 2-fold reduction in the rate of metabolism was measured in the absence of microsomal cytochrome This article has not been copyedited and formatted. The final version may differ from this version. Figure 6A ). When 17α hydroxy-progesterone was used as a substrate to investigate the effect of cytochrome b 5 deletion on Cyp17-lyase activities, testicular BCN microsomes had almost no activity, being 100-fold lower than wild-type controls (p < 0.001) ( Figure 6A ).
Since Cyp17 and 17β-hydroxysteroid dehydrogenase (17βHSD) are both microsomal NADPH-dependent enzymes (Fig 6C) , incubations with 17α hydroxy-progesterone also yielded the metabolite testosterone (produced by the metabolism of androstenedione by 17βHSD ( Figure 6C) ). Testicular microsomes from wild-type mice were 66-fold more active than BCN in the production of testosterone from androstenedione formed by the Cyp17 (Fig   6A) . A reflection of this reduction in levels of testosterone was also observed in vivo, as when testes from wild-type and BCN mice were analyzed for testosterone content, BCN samples contained significantly less testosterone than wild-type (approximately 1.8 fold)
( Figure 6B ). There were no compensatory alterations in the levels of Cyp17 protein expressed in the testes of cytochrome b 5 null mice ( Figure 6D ).
DISCUSSION
Due to the large number of functions associated with cytochrome b 5 , which include fundamental processes such as steroid hormone biosynthesis and haemoglobin homeostasis (Porter, 2002; Schenkman and Jansson, 2003) , it would be predicted that the deletion of this enzyme could be lethal. Unexpectedly, this was not the case, with BCN pups produced at expected Mendelian ratios with no gross anatomical abnormalities. In addition, no overt reduction in fertility was observed in either sex. Interestingly however, several phenotypic characteristics were identified including skin defects closely resembling the human condition Ichthyosis Vulgaris, which were exacerbated in breeding females on the birth of successive litters.
Until the publication of our recent paper detailing the conditional hepatic deletion of microsomal cytochrome b 5 (Finn et al., 2008) , investigation of the role of cytochrome b 5 in drug metabolism was based on in vitro studies (Gruenke et al., 1995; Yamazaki et al., 1996; Yamazaki and Shimada, 2006) or heterologous over-expression of proteins (Patten and Koch, 1995 was also observed when hepatic POR was conditionally (Gu et al., 2003; Henderson et al., 2003) which in this latter case, appears to be due to activation of the constitutive androstane receptor and, to a lesser degree, the pregnane X receptor by accumulated polyunsaturated fatty acids (Finn et al., 2009) . No such increases were found in BCN mice which unlike the HRN mice, did not have a fatty liver, indicating that the activation is the result of an alternative metabolic pathway.
Investigation of the in vitro metabolism of cytochrome P450 substrates produced some unexpected and interesting results (Table 1) . NADH-mediated metabolism was undetectable in BCN mice, demonstrating that cytochrome b 5 is an unequivocal electron donor to cytochrome P450s. For NADPH-dependent metabolism, BCN hepatic microsomes exhibited the same magnitude of decrease in the metabolism of the alkoxy-trifluoromethylcoumarins as previously observed in HBN mice (Finn et al., 2008) ; however, there were some differences between these models with alkoxy-resorufin metabolism. Turnover of MR and ER in BCN hepatic microsomes was essentially unchanged from the rates observed in wild-type, while in the HBN microsomes, ER O-deethylase activity was approximately 26% lower (Finn et al., 2008) . This difference could be explained by the finding that compensatory changes in cytochrome P450 gene expression in BCN mice were not observed in HBN animals, therefore the ratio of different P450s to each other as well as their absolute levels is different between the lines. These data suggest that cytochrome b 5 plays little role in the metabolism of Cyp1a
substrates. In support of this, the metabolism of BR and PR, traditionally attributed to Cyp2b enzymes, was increased 4.1-and 2.4-fold, respectively, correlating very well with the markedly higher levels of hepatic Cyp2b expression in BCN samples ( Figure 2B,C) . In the HBN model, BR was metabolized significantly slower (30%) of the wild-type rate (Finn et al., 2008) . Indeed, Cyp2b10 levels were elevated 17-fold in BCN liver which would therefore equate to a predicted maximal 5.1-fold increase in turnover (17 x 30% activity), close to the for both BR and BFC activity, resulting in activities 2.3-and 7.8-fold higher than wild-type for BFC and BR, respectively. This "super-activation" of turnover can be attributed to the increased levels of Cyp2b (BR and BFC activity), and Cyp2a and Cyp3a (BFC) in the livers of BCN animals ( Figure 2B,C) . Furthermore, addition of exogenous cytochrome b 5 to wildtype lung microsomes, unlike hepatic microsomes, significantly stimulated turnover; most markedly during BR O-dealkylation (6.8-fold). Together, these data suggest that, in the lung, cytochrome b 5 is a key component of the cytochrome P450 monooxygenase system (Croft et al., 1986) , the constitutive levels of which for the metabolism of some substrates are rate limiting.
When the effect of cytochrome b 5 deletion was investigated using a set of probe drugs, To investigate more fully the mechanism of cytochrome b 5 interaction with cytochrome P450, the kinetic parameters of MR, which is metabolized by Cyp1a2, and is unaffected by cytochrome b 5 (Table 1) and BFC, which is metabolized by multiple P450s (Cyp3a, Cyp2a Cyp2b, Cyp2c) and is significantly affected by cytochrome b 5 , were determined. The K m and V max for MR were not markedly different between BCN and wildtype, while for BFC there was a 5-fold increase in K m and a 4.5-fold decrease in V max in the BCN samples (Table 2 ). The alteration in K m for BFC provides evidence to support theory that cytochrome b 5 effects P450 activity through allosteric interactions with the metabolising cytochrome P450s, causing a conformational shift in the active site, which affects substrate binding (Bridges et al., 1998; Hlavica and Lewis, 2001) . Alternatively, the change in K m observed for BFC could be attributable to multiple P450s, differentially upregulated by the deletion of cytochrome b 5 contributing to the metabolism of this substrate. There is evidence to support the binding of cytochrome b 5 to mammalian CYP1A2 (Shimada et al., 2005) , therefore the lack effect on the K m for MR in the BCN samples suggests that cytochrome b 5 binding does not significantly alter Cyp1a2 active site conformation. This is supported by evidence which indicates that unlike enzymes such as CYP3A4 and CYP2B4, CYP1A2 has an extremely stable and inflexible active site (Anzenbacher and Hudecek, 2001 ).
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be assessed in greater detail. We have previously shown that hepatic deletion of cytochrome
did not make a significant difference to the in vivo metabolism of metoprolol (Finn et al., 2008) . In contrast, determination of the in vivo pharmacokinetic parameters of metoprolol in BCN mice provides evidence that extra-hepatic tissues play a key role in its metabolism, as in this model the AUC and C max are increased 3.5-and 4-fold, respectively, and clearance is decreased by 3.5-fold compared to wild-type mice ( Figure 5 ). In support of this, it has recently been shown that in mouse, intestinal P450s play important roles in drug pharmacokinetics (van Herwaarden et al., 2009) . These data reinforce our previous conclusions that the level and/or the activity of cytochrome b 5 can play a significant role in the metabolism, disposition and therapeutic effectiveness of clinically used drugs.
A particularly well-characterised role for cytochrome b 5 is in steroid hormone biosynthesis, where it enhances the lyase activity of Cyp17 through an allosteric mechanism while having little effect on the hydroxylase activity (Akhtar et al., 2005; Auchus et al., 1998; Naffin-Olivos and Auchus, 2006) . Testicular Cyp17 activity was severely compromised in BCN samples not only for the lyase reaction (1% of wild-type), but also in progesterone hydroxylation (50% of the wild-type rate) ( Figure 6A ). In addition BCN mice had a significantly lower concentration of testicular testosterone ( Figure 6B ), with no change in levels of Cyp17 protein observed ( Figure 6D ). It appears therefore, that although Cyp17 lyase activity is almost completely cytochrome b 5 dependent, the presence of cytochrome b 5 is not an obligatory requirement for successful testosterone biosynthesis.
In summary, we have generated a mouse model in which microsomal cytochrome b 5 is completely deleted, and characterised the effect on cytochrome P450 expression and This article has not been copyedited and formatted. The final version may differ from this version. 
